Evidence map›Paper›PMID 42146824›Full record

ArticleAnnals of gastroenterological surgery2026

Visionary Leadership in Cancer Care: An Interview With Professor Timothy J. Eberlein.

Ken Shirabe, Koshi Mimori, Masaki Mori, Yuko Kitagawa

Abstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ken ShirabeDepartment of General Surgical Science Graduate School of Medicine Maebashi Gunma Japan.ORCID https://orcid.org/0000-0002-7173-7945
Koshi MimoriDepartment of Surgery Kyushu University Beppu Hospital Beppu Oita Japan.ORCID https://orcid.org/0000-0003-3897-9974
Masaki MoriDepartment of Gastroenterological Surgery Tokai University School of Medicine Isehara Kanagawa Japan.
Yuko KitagawaDepartment of Surgery Keio University School of Medicine Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a short interview with Professor Timothy J. Eberlein, conducted by Professor Ken Shirabe, President of the Japanese Society of Gastroenterological Surgery, explores the vision, strategies, and leadership behind developing the Siteman Cancer Center into a world-class institution. Professor Eberlein emphasizes two central goals: becoming experts in every type of cancer and ensuring that every patient feels uniquely cared for. He highlights the importance of large-scale clinical programs in sustaining a virtuous cycle of academic medicine, where clinical revenue supports research and education, and innovations attract both patients and trainees. A distinctive element of his philosophy is individualized training, offering flexibility for surgical residents to focus on areas such as oncology, minimally invasive surgery, or education. He underscores the critical role of mentorship, collaboration, and laboratory organization in nurturing surgeon-scientists. Balancing surgery and research is described as a delicate challenge, but one that can be overcome with proper mentorship and collaboration. Leadership is about leading by example, solving problems for others, and respecting every member of the healthcare team. He stresses that surgery is the ultimate team sport, with outcomes dependent on the collective contributions of diverse professionals. Finally, his message to the next generation of surgeons and oncologists in Japan is to maintain their passion, embrace innovation, and realize that the future holds opportunities, such as genetic therapies, vaccines, and immune therapies that will revolutionize cancer treatment when combined with surgical expertise.

Indexed as

academic medicine (virtuous cycle)cancer center leadershipsurgical education and mentorship

Identifiers

PMID42146824
PMCPMC13178276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.